Downregulation of Long Noncoding RNA LINC00261 Attenuates Myocardial Infarction through the miR-522-3p/Trinucleotide

Chaoxin Jiang1, Qing Zhao2, Chenlong Wang3

  • 1Department of Clinical Laboratory, Guangdong Provincial Hospital of Integrated Traditional Chinese and Western Medicine, Foshan, Guangdong 528200, China.

Abstract

Insights

Long noncoding RNA LINC00261 exacerbates myocardial infarction (MI) by downregulating miR-522-3p, leading to increased TNRC6A expression and cardiomyocyte apoptosis. LINC00261 inhibition shows therapeutic potential for MI treatment.

Area of Science:

  • Molecular Biology
  • Cardiovascular Research
  • Genetics

Background:

  • Myocardial infarction (MI) involves cardiac tissue death due to prolonged coronary artery ischemia.
  • Investigating the role of long noncoding RNA (lncRNA) LINC00261 in MI pathogenesis is crucial.
  • Understanding the molecular mechanisms underlying MI can lead to novel therapeutic strategies.

Purpose of the Study:

  • To investigate the expression of lncRNA LINC00261 in myocardial infarction (MI).
  • To elucidate the regulatory network involving LINC00261, miR-522-3p, and TNRC6A in MI.
  • To assess the therapeutic potential of targeting LINC00261 in MI treatment.

Main Methods:

  • Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) to measure LINC00261, miR-522-3p, and TNRC6A expression.
  • Western blotting to detect TNRC6A protein levels.
  • Cell viability and apoptosis assays in cardiomyocytes with manipulated LINC00261 and TNRC6A levels.
  • Double luciferase reporter assays to confirm molecular interactions.

Main Results:

  • LINC00261 and TNRC6A were upregulated, while miR-522-3p was downregulated in MI tissues.
  • LINC00261 knockout enhanced cardiomyocyte viability and reduced apoptosis.
  • LINC00261 directly targets miR-522-3p, which in turn targets TNRC6A, influencing cardiomyocyte apoptosis in MI.

Conclusions:

  • LINC00261 downregulates miR-522-3p in MI cardiomyocytes via direct targeting.
  • TNRC6A is a direct target of miR-522-3p, mediating MI-related effects.
  • LINC00261 presents a potential therapeutic target for myocardial infarction treatment.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.2K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
22.6K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.6K
Types of RNA01:20

Types of RNA

Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
7.2K